Company Information

  

Address: 101 HARTWELL AVENUE  
City: LEXINGTON 
State: MA 
Zip Code: 02421 
Telephone: 781-457-1200 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

We are an in vitro diagnostics company that has developed an innovative and proprietary technology platform that offers a rapid, sensitive and simple alternative to existing diagnostic methodologies. We are using our T2 Magnetic Resonance technology, or T2MR, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. T2MR enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter, or CFU/mL. Our initial development efforts target sepsis and Lyme disease, which are areas of significant unmet medical need in which existing therapies could be more effective with improved diagnostics.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-1.97NAN/E
03/2017-2.04NAN/E
12/2016-2.11NAN/E
09/2016-2.21NAN/E
06/2016-2.27NAN/E
03/2016-2.23NAN/E
12/2015-2.21NAN/E
09/2015-0.54NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.23Total Liab/Total Assets0.56
Net Inc/Total Assets-0.61Total Liab/Inv Cap0.64
Net Inc/Inv Cap-0.70Total Liab/Comm Equity0.21
Pretax Inc/Net Sales-13.43Interest Coverage Ratio-12.37
Net Inc/Net Sales-13.43Curr Debt/Equity0.03
Cash Flow/Net Sales-11.38LTD/Equity1.00
SG&A/NetSales5.90Total Debt/Equity1.04
Asset Utilization   Liquidity  
Net Receivables Turnover11.72Quick Ratio7.55
Inventory Turnover9.25Current Ratio7.63
Inventory Day Sales0.02Net Rec/Curr Assets0.00
Net Sales/Work Cap0.06Inv/Curr Assets0.01
Net Sales/PP&E0.30  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 0.96 0.94 0.91 1.09
Cost of Goods Sold 1.99 1.63 2.17 1.89
Selling & Admin Exps 5.76 5.87 5.80 5.94
Operating Income -13.91 -13.15 -12.91 -11.95
Interest Exp 1.65 1.64 1.68 0.88
Pretax Income -15.46 -14.70 -14.55 -12.78
Other Income 0.10 0.08 0.04 0.04
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -15.46 -14.70 -14.55 -12.78

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 46.13 58.82 73.49 75.11
Receivables - Total 0.98 0.41 0.33 0.38
Inventories - Total 1.01 0.49 0.80 1.34
Total Current Assets 48.79 60.65 75.44 77.78
Net Property, Plant & Equipment 14.51 14.47 13.59 13.63
Total Assets 63.78 75.66 89.57 92.00
Liabilities        
Accounts Payable 6.36 5.22 5.87 5.93
Debt in Current Liabilities 1.37 1.32 1.27 11.50
Total Current Liabilities 10.47 8.91 9.89 18.54
Long-Term Debt 39.91 39.75 39.50 21.25
Total Liabilities 51.45 49.63 50.23 41.42
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.03 0.03 0.03 0.03
Retained Earnings -233.85 -218.39 -203.69 -189.14
Treasury Stock NA NA NA NA
Total Stockholders' Equity 12.33 26.03 39.34 50.58
Total Liabilities and Stockholders' Equity 63.78 75.66 89.57 92.00

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -12.22 -12.76 -10.30 -11.36
Net Cash Provided by Investing Activities -0.87 -1.59 -0.89 -1.42
Net Cash Provided by Financing Activities 0.41 -0.31 9.57 37.67

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.02-14.46--
12/20130.27-20.61--
12/20140.12-31.39-4.15
12/20152.81-45.29-2.21
12/20164.08-54.80-2.11
Growth Rates282.80----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/175918,62752.04




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.